GlaxoSmithKline today announced that the US Food and Drug Administration (FDA) has approved updated US prescribing information for the thiazolidinediones (TZD) class of medicines used in the treatment of Type 2 diabetes. This approval allows GSK to implement changes in the label for Avandia® (rosiglitazone maleate) as previously committed.
The label will contain a boxed warning, which increases the prominence of an already existing warning for all medicines in the TZD class on the risk of congestive heart failure (CHF), a well known and well characterized risk in this class of medicine.
Via: Medical News Today.Com/Diabetes
“GlaxoSmithKline Updates Prescribing Information For Avandia In The US”
Researchers at the University of Pennsylvania School of Medicine have found that a commonly prescribed diabetes drug kills tumor cells that lack a key regulatory gene called p53. Results from current studies in mice may result in new therapies for a subset of human cancers that tend to be aggressive and resistant to existing treatments.
[...skipping to the end of the article we find out "which" drug they are talking about...]
… the regulation of metabolic pathways by p53 is also influenced by metformin, the most widely used diabetes drug. Metformin activates the metabolic enzyme AMPK, which exerts changes on cellular metabolism by affecting p53 function. Two observational studies already show that diabetic patients who take metformin have a lower rate of cancer diagnosis and mortality than other diabetics.
Via: India Daily
“Researchers find diabetes drug kills some cancer cells”
A global manhunt begun by Johnson & Johnson has traced to China counterfeit versions of an at-home diabetes test used by 10 million Americans to take sensitive measurements of blood sugar levels.
Potentially dangerous copies of the OneTouch Test Strip sold by Johnson & Johnson’s LifeScan unit surfaced in U.S. and Canadian pharmacies last year, according to federal court documents unsealed in June.
Court filings disclose, for the first time, that China is the source of about one million phony test strips, which have turned up in at least 35 states and in Canada, Greece, India, Pakistan, the Philippines, Saudi Arabia and Turkey.
Johnson & Johnson, the world’s largest consumer-health products maker, learned of the counterfeit tests after 15 patients complained of faulty results last September.
Via: International Herald Tribune
“Johnson & Johnson tracks down maker of phony diabetes test”
Jo says: More from China!
___________________________________________
Diabetes 
Type 1 Diabetes 
Type 2 Diabetes
Leave a Reply